p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6690298.pdf
Reference49 articles.
1. Auer, G., Einhorn, N., Nilsson, B., Silfversward, C. & Sjovall, K. (1996). Biological malignancy grading in early-stage ovarian carcinoma. Acta Oncol 8: 93–98.
2. Backe, J., Gassel, A. M., Hauber, K., Krebs, S., Bartek, J., Caffier, H., Kreipe, H-H, Muller-Hermelink, H-K & Dietl, J. (1997). p53 protein in endometrial cancer is related to proliferative activity and prognosis but not to expression of p21 protein. Int J Gynecol Pathol 16: 361–368.
3. Barboule, N., Mazars, P., Baldin, V., Vidal, S., Jozan, S., Martel, P. & Valette, A. (1995). Expression of p21WAF1/CIP1 is heterogeneous and unrelated to proliferation index in human ovarian carcinoma. Int J Cancer 63: 611–615.
4. Boring, C. C., Squires, T. S., Tong, T. & Montgomery, S. (1994). Cancer statistics, 1994. CA Cancer J Clin 44: 7–26.
5. Bukholm, I. K., Nesland, J. M., Karesen, R., Jacobsen, U. & Borresen, A. L. (1997). Relationship between abnormal p53 protein and failure to express p21 protein in human breast carcinomas. J Pathol 181: 140–145.
Cited by 72 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Integrated transcriptome and cell phenotype analysis suggest involvement of PARP1 cleavage, Hippo/Wnt, TGF-β and MAPK signaling pathways in ovarian cancer cells response to cannabis and PARP1 inhibitor treatment;Frontiers in Genetics;2024-01-23
2. Cellular senescence in cancer: clinical detection and prognostic implications;Journal of Experimental & Clinical Cancer Research;2022-12-27
3. Survivin, sonic hedgehog, krüppel-like factors, and p53 pathway in serous ovarian cancer: an immunohistochemical study;Human Pathology;2022-09
4. Advances in the Biological Functions and Mechanisms of miRNAs in the Development of Osteosarcoma;Technology in Cancer Research & Treatment;2022-01
5. Inhibition of CDK4/6 as Therapeutic Approach for Ovarian Cancer Patients: Current Evidences and Future Perspectives;Cancers;2021-06-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3